How Much Did Amplion Raise?
Funding & Key Investors

Amplion, a prominent player in the precision medicine intelligence sector, has successfully secured a total of $1.7M in capital to date. This trajectory of financial backing underscores the company's critical role in the life sciences ecosystem. Most recently, the firm finalized a major strategic investment of $368K, marking a significant milestone in its operational expansion and reinforcing its commitment to providing data-driven insights for complex drug discovery and development workflows.

What is Amplion?

Amplion
SoftwareBusiness Intelligence (BI) SoftwareHealthcare Software

Founded in 2013 and headquartered in Bend, Oregon, Amplion operates at the intersection of big data and biotechnology. The company provides a sophisticated platform that delivers evidence-based intelligence, enabling science teams to navigate the complexities of precision medicine with greater accuracy. By streamlining the decision-making process for drug discovery, development, and companion diagnostics, Amplion has established itself as an essential partner for organizations aiming to accelerate therapeutic innovation. The platform serves as a central repository for actionable insights, effectively bridging the gap between raw scientific data and strategic commercial application in the rapidly evolving healthcare landscape.

How much funding has Amplion raised?

Amplion has raised a total of $1.7M across 3 funding rounds:

2014

Angel/Seed

$1M

2020

Debt

$350K

2021

Debt

$368K

Angel/Seed (2014): $1M with participation from Seven Peaks Ventures

Debt (2020): $350K led by PPP

Debt (2021): $368K supported by PPP

Key Investors in Amplion

Seven Peaks Ventures

Seven Peaks Ventures is a venture capital firm that partners with entrepreneurs to build and scale disruptive, category-leading businesses across sectors including AI, robotics, and space technology.

PPP

Public-Private Partnership

PPP

Public-Private Partnership

What's next for Amplion?

With the infusion of $368K, Amplion is well-positioned to scale its enterprise-level intelligence capabilities. The company is expected to focus on enhancing its algorithmic precision and expanding its data coverage to support broader therapeutic areas. As the precision medicine market continues to mature, Amplion's strategic roadmap likely involves deepening its integration within the R&D pipelines of global pharmaceutical firms. By leveraging its recent capital injection, the firm aims to solidify its market leadership, ensuring that its evidence-based intelligence remains the gold standard for teams tasked with bringing the next generation of life-saving treatments to market.

See full Amplion company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Content & Collaboration SoftwareSoftwareCustomer Engagement Platforms
Engineering SoftwareSoftware
Customer Engagement PlatformsSoftwareColleges & UniversitiesEducation
Financial SoftwareSoftwareBusiness ServicesSoftware TestingMobile App Development

Frequently Asked Questions Regarding Amplion Financial Insights

What are the most recent funding rounds that Amplion has completed, and what were the funding rounds?
Amplion has recently completed 3 funding rounds: Debt on Feb 26, 2021, Debt on Apr 13, 2020, Angel/Seed on Dec 30, 2014.
What is the total amount of funding Amplion has raised to date?
Amplion has raised a total of $1.7M in funding to date.
How many funding rounds has Amplion completed?
Amplion has completed 3 funding rounds.
How much funding did Amplion raise in its most recent funding round?
Amplion raised $368K in its most recent funding round.
Who are the lead investors in Amplion's latest funding round?
The lead investor in Amplion's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Amplion's history?
The largest funding round in Amplion's history was $1M.
See more information about Amplion